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ABSTRACT 
A cross sectional study was done to examine the performance of SF-36 and the Malay translated Audit of 
Dependent Diabetes Quality of Life (ADDQOL). Univariate analysis showed there was no significant 
dzfference in the ADDQOL scores. Ancova showed that Vitality score and Bodily Pain score was different 
in some areas. Only Mental Health scales were different between sexes among all scales in SF-36.The 
Malay translated ADDQOL and most of SF-36 performances were mostly not affected by different gender, 
types of treatments, glycemic controls andpresence of complications. 
Keywords: Quality of l i fe,  Audit of Diabetes Dependent Quality of Life (ADDQOL), Short-Form 36 (SF- 
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INTRODUCTION 
Most studies have reported worse Quality Of 
Life (QOL) for people with diabetes, compared 
to persons without diabetes, especially in 
physical functioning and well-being aspects 
(Rubin and Peyrot, 1999). There are 2 strategies 
for quality of life evaluation; the measures that 
address illness-specific issues and the measures 
that address a wide spectrum of conditions also 
known as generic instruments (Jacobson et al., 
1994). To assess quality of life (QOL) proper 
QOL measure or instrument is important for 
many reasons. For example using a health status 
measure questionnaire despite entirely QOL 
measures to assess QOL, may give misleading 
conclusions (Bradley, 2001). Influence of the 
demographic, medical history and self- 
management characteristics on the QOL has been 
studied elsewhere (Glasgow, R.E. et al., 1997). It 
was found that the more intensive the treatment, 
the better the chance to delay the onset and 
progression of complications (Hart, H.E. et al., 
2003) but with adverse effects on the QOL. An 
example was when the type 2 diabetics on insulin 
reported a greater impact on the quality of life 
than did those on oral medication (Glasgow, R.E. 
et al., 1997) . It was suggested that QOL score 
did not differ significantly between the 'good 
control' group and 'poor control group'. 
However the QOL scores between 'insulin 
treated' group and 'non-insulin treated' group 
differed significantly in social functioning, 
mental state and pain (Goddijn, P.P.M. et al., 
1999). Apart from that the QOL can be affected 
by different types of treatments, complications 
(Jacobson, A.M. et al., 1994) and the presence of 
symptoms for hyperglycaemia (Goddijn, P.P.M. 
et al., 1999). Presence of late complications was 
associated with different scales of QOL (Bott, U. 
et al., 1998) with the presence of macrovascular 
complications definitely has large negative 
impact on the QOL (Hart, H.E. et al., 2003). The 
development of microvascular complications was 
also related to decrements in QOL (Ahroni, J.H. 
and Boyko, E.J., 2000). The objective of the 
study was to measure the performance of SF-36 
and the Malay translated Audit of Dependent 
Diabetes Quality of Life (ADDQOL) among type 
2 diabetes patients in different gender, types of 
treatments, glycemic control and presence of 
complications. 
MATERIALS AND METHOD 
Design And Respondents 
The study was a cross sectional study and the 
respondents were patients with type 2 diabetes 
mellitus who were attending diabetic clinics in 
Kelantan. Altogether 172 subjects were included 
and were given two self-administered measures 
(questionnaires) after they had been 
systematically and randomly selected. 
Inclusion And Exclusion Criteria 
* Department of Cornmunip Medicin, School The respondents should have been diagnosed 
of Medical Sciencese,Universiri Sains with type 2 diabetes mellitus at least for 1 year 
Malaysia (USA) Kelantan and all of them should be above 18 years of age. 
School of Denral Science (USM), Kelantan They must be able to read and write in Malay 
Department of Medecine Sckool of Medical 
Sciences. UShf Kelantan language. The respondents would be excluded if 
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they have been diagnosed with cognitive 
impairment or were having suspected substance 
abuse disorder. 
Tools 
2 questionnaires, The Malay translated and 
validated Audit of Diabetes Dependent Quality 
of Life (ADDQOL) and the Malay translated and 
validated Short-Form 36 (SF-36) were self- 
administered by the selected respondents. The 
ADDQOL has 2 overview items and 18 other 
specific items (Bradley C et al., 1999). 
Meanwhile the SF-36 includes one multi-item 
scale that measures eight health concepts that is 
Physical functioning (PF), Role limitations due 
to physical health problems (RP), Bodily pain 
(BP), General health (GH), Vitality 
(energylfatigue) (VITA), Social hnctioning 
(SF), Role limitations due to emotional problems 
(RE) and Mental health (MH) (Ware J E et al., 
1993) 
STATISTICAL ANALYSES 
For univariate analysis, t-test was used. For the 
multivariable analysis we used analysis of co- 
variance (ANCOVA) where the duration of 
being diagnosed as diabetic and age in years of 
the respondents were adjusted. 
RESULTS 
Table I shows the characteristic of the 
respondents and the means, standard deviations 
and the 95% confidence interval for means. The 
ADDQOL has shown negative results suggesting 
the adverse effect on the QOL from having 
diabetes mellitus. The scores of the scales in SF- 
36 were also generally lower. They ranged from 
47.96 to 68.14. In Table 11, the p-values from the 
t-test or univariate analysis were shown. There 
were significant different scores between 
different gender in Mental health (MH), between 
treatment in Bodily pain and glycemic control in 
Vitality (VITA) and also Mental health (MH). 
The presence of complication did not shown 
significant different in the respondents. The 
results from the ANCOVA are shown in Table 
111. After adjustment, the estimated marginal 
means were significantly different in gender for 
Mental health. Different treatment has significant 
effect also on the Mental health. Glycemic 
control on the other hand significantly affected 
Vitality. Larger sample size may render the 
Bodily pain and Mental health status significant 
in different respondents. 
Table I: Characteristics of the respondents and the summary of ADDQOL and SF-36 
Descriptives 
--- - - 
Statistics 
95% Confidence Interval for 
Mean 
Mean Lower Bound Upper Bound Std. Deviation 
Statistic AGE 52.37 50.92 53.81 9.35 
HBA l C 8.96 8.60 9.33 2.42 
YEARS OF DIAGNOSIS 8.69 7.71 9.67 6.38 
ADDQOL SCORE -4.24 -4.55 -3.93 2.02 
SF-36 PHYS1CA.L 
FUNCTIONING 
SF-36 ROLE PHYSICAL 47.96 4 1.04 54.88 42.45 
SF-36 MENTAL HEALTH 67.78 64.88 70.68 17.73 
SF-36 BODILY PAIN 42.37 40.73 44.02 10.07 
SF-36 MENTAL HEALTH 54.13 5 1.03 57.23 18.82 
SF-36 VITALITY 56.87 53.76 59.98 19.10 
SF-36 SOCIAL FUNCTINONG 68.14 64.42 71.87 22.61 
SF-36 ROLE EMOTIONAL 58.96 51.84 66.07 43.63 
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Table 2: p-value of t-test between different gender, treatment, 
complication and glycemic control 
Gender Treatment Complication Glycemic 
control 
ADDQOL 0.38 0.7 1 0.53 0.33 
PF 0.25 0.81 0.22 0.4 1 
RP 0.86 0.79 0.75 0.65 
B P 0.11 0.03 0.75 0.32 
GH 0.90 0.60 0.50 0.28 
VITA 0.42 0.47 0.87 0.03 
SF 0.35 0.86 0.69 0.2 1 
RE 0.40 0.20 0.33 0.61 
MH 0.04 0.69 0.34 0.03 
Table 3: F-statistics and p-value* of ANCOVA between different gender, treatment, 
complication and glycemic control with adjustment of duration of being diagnosed 
as diabetics and age of respondents 
- -- 
Gender Treatment Complication Glycemic control 
ADDQOL 0.15(0.07) 0.12(0.73) 1.04(0.3 1) 0.76(0.39) 
PF 2.26(0.14) 0.34(0.56) 0.75(0.39) 1.86(0.17) 
RP 0.86(0.36) 1.35(0.25) 0.28(0.60) 0.22(0.63) 
BP 3.90(0.05) 2.15(0.15) 0.50(0.48) 0.38(0.54) 
GH 0.16(0.69) 0.16(0.69) 0.69(0.4 1) 1 .O l(0.32) 
VITA O.SS(0.35) 0.67(0.42) 0.02(0.89) 5.52(0.02) 
SF 3.00(0.19) 0.50(0.48) O.OO(0.99) 0.27(0.60) 
RE O.Ol(0.94) 0.50(0.48) O.OO(0.99) 0.27(0.60) 
MH 5.38(0.02) 0.02(0.89) 0.98(0.32) 3.83(0.05) 
* ( ) = p-value 
DISCUSSION 
In this study, the respondents with good 
glycemic control have higher vitality score and 
mental health scores (means not shown) and this 
was consistent with some. other studies. As 
expected males respondents have better mental 
status scores, and this finding was similar with a 
study elsewhere (Redekop et al., 2002). The 
score of Bodily pain was significantly better in 
those with less intensified treatment and this is 
acceptable as more intensified treatment with 
insulin may impair the life of the patient. 
Contrary to some other studies, we did not find 
significant difference in both the ADDQOL and 
SF-36 scores for respondents with and without 
complications. This probably due to our 
respondents that were almost all being selected 
from outpatients clinics. We would expect 
different results if we were to select respondents 
from inpatients wards. There are 8 subscales in 
SF-36, which some may be the unnecessary to 
assess QOL thus have given inconsistent results 
in this study. These findings supported the 
suggestion that proper domains selection and 
inclusion must be practiced to assess QOL 
(Bradley, C. et al., 1999). Different information 
from different instruments (Goddijn et al., 1999) 
may also explain inconsistent result between 
ADDQOL and SF-36. Thus researchers must be 
careful when selecting tools to assess the QOL 
because some instruments such as the SF-36 
were health functional status instruments rather 
than an entirely a QOL instrument. Treatment 
intensification from diet only to oral agents to 
insulin was associated with decrements in quality 
of life in other study (Rubin, R.R. and Peyrot, 
M., 1999). Similar result except for Bodily pain 
was not shown here probably due to different 
methods of grouping the treatments. This finding 
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warrant further study to assess whether the 
bodily pain score was due to the insulin 
treatment or just the manifestation of co- 
morbidity. Different aim of measures such as 
ADDQOL for QOL and SF-36 for functional 
status or 'health status' may give rise to 
conflicting results (Fayers and Machin, 2000). 
However the inconsistency was small between 
the SF-36 and ADDQOL suggesting that both 
instruments can complement each other in such 
that the SF-36 for perceived health and the 
ADDQOL for individual QOL (Woodcock et al., 
2001). The limitations of the study were that this 
was a cross sectional study where causal 
relationship could not be established. The 
secondary information about the clinical aspects 
that were collected may be incorrect or 
insufficiently documented. There was possibility 
that some patients might have not been examined 
properly. The complication is best divided into 
microvascular and macrovascular and the 
number of complications counted. Different 
setup and clinics work process may have given 
rise to different treatments regimes and may have 
influenced the measurement. The treatment 
should be best grouped into diet, oral only, 
insulin and oral and insulin which were not done 
here because of small sample size. 
CONCLUSION 
ADDQOL as a specific diabetes questionnaire 
for QOL measure may complement SF-36 as a 
functional status measure to give more accurate 
information of a well-being in type 2 diabetes 
patients. 
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